Overview
Elodie Belnoue practices practicing medicine in Geneve, Switzerland.
Her clinical expertise encompasses Familial Colorectal Cancer, Colorectal Cancer, and Neuroendocrine Tumor.
She is actively involved in clinical research, co-authoring 15 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Elodie Belnoue
Is Elodie Belnoue a top-rated expert for Familial Colorectal Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Elodie Belnoue is classified as an Experienced expert for Familial Colorectal Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Elodie Belnoue participate in research or clinical trials?
Yes. Elodie Belnoue has published 15 articles and abstracts on conditions like Familial Colorectal Cancer. You can view a list of Elodie Belnoue's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Colorectal CancerMs. Belnoue isExperienced. Learn about Colorectal Cancer.
- Familial Colorectal CancerMs. Belnoue isExperienced. Learn about Familial Colorectal Cancer.
- Neuroendocrine TumorMs. Belnoue isExperienced. Learn about Neuroendocrine Tumor.